LMC Login | CPMC Login | My Games Account Login
Change Region: Asia | Europe | USA | UK | RoW
Register for Updates & Free Games Account
Complete the form below to register with us for updates. We will update you when new challenges and games are available to play.
First Name:
Surname:
Country:
Email:
Re-enter email:
If you would like a free PharmaSchool Games Account so you can record your weekly GCP Challenge Scores please check the box below and add a password:
Free Games Account:
Password:
Re-enter Password:
 
 
 
Weekly GCP Challenge

Answer the questions below and then click the button. The next page will mark your answers and show you how well you have done compared with the previous people who have taken the tests.


Challenge: Regulatory - What is it? II

Question Number 1:
CMC is a component of an application for approval to market a new pharmaceutical product. What is the CMC Component concerned with?
A
Cardiac Adverse Events and Safety
B
Certification of Medical Competency
C
Chemistry and Manufacturing
D
Cumulative Metabolites

Question Number 2:
Medicines can be authorised for marketing in the European Union by using either the national authorisation procedures or by which other method?
A
Mutual Recognition Procedure
B
Decentralised Authorisation Procedure
C
Non-Central Drug Application Authorisation Procedure
D
Centralised Authorisation Procedure

Question Number 3:

In the USA current Federal law requires that a drug be the subject of an approved marketing application before it is transported or distributed across state lines. A sponsor will need to ship the investigational drug to clinical investigators in many states. To do this the sponsor must seek an exemption from the legal requirement of having to hold the approved marketing application. Through what method does the sponsor technically obtain this exemption from the FDA?

A
NDA
B
ANDA
C
IND
D
MAA

Question Number 4:

Approximately how much is the fee for to submit an new drug application to the US FDA that contains data from clinical trials?

A
$15,000
B
$150,000
C
$1,500,000
D
$15,000,000

Question Number 5:

In 1992 a law was passed in the USA to allow the FDA to collect fees from sponsors to fund the new drug review and approval process. What is this law better known as?

A
PUMA
B
PDUFA
C
FNDA
D
Sarbanes-Oxley Act

Sort the Challenges
GCP & Guidelines
Trial Design
Adverse Events
Monitoring
Statistics
Abbreviations
General
Show All
International Sites: USA Europe Asia Rest of World
PharmaSchool Ltd. Registered in England & Wales No: 05439862
t: +44 (0) 845 224 0891 f: +44 (0) 845 224 0873 e: info@pharmaschool.co.uk